학술논문

Genome-wide association analysis identifies 13 new risk loci for schizophrenia
Document Type
article
Source
Nature Genetics. 45(10)
Subject
Mental health
Case-Control Studies
Female
Genetic Predisposition to Disease
Genome-Wide Association Study
Humans
Male
Polymorphism
Single Nucleotide
Schizophrenia
Sweden
Multicenter Genetic Studies of Schizophrenia Consortium
Psychosis Endophenotypes International Consortium
Wellcome Trust Case Control Consortium 2
Biological Sciences
Medical and Health Sciences
Developmental Biology
Language
Abstract
Schizophrenia is an idiopathic mental disorder with a heritable component and a substantial public health impact. We conducted a multi-stage genome-wide association study (GWAS) for schizophrenia beginning with a Swedish national sample (5,001 cases and 6,243 controls) followed by meta-analysis with previous schizophrenia GWAS (8,832 cases and 12,067 controls) and finally by replication of SNPs in 168 genomic regions in independent samples (7,413 cases, 19,762 controls and 581 parent-offspring trios). We identified 22 loci associated at genome-wide significance; 13 of these are new, and 1 was previously implicated in bipolar disorder. Examination of candidate genes at these loci suggests the involvement of neuronal calcium signaling. We estimate that 8,300 independent, mostly common SNPs (95% credible interval of 6,300-10,200 SNPs) contribute to risk for schizophrenia and that these collectively account for at least 32% of the variance in liability. Common genetic variation has an important role in the etiology of schizophrenia, and larger studies will allow more detailed understanding of this disorder.